[HTML][HTML] Light-based technologies for management of COVID-19 pandemic crisis

CP Sabino, AR Ball, MS Baptista, T Dai… - … of Photochemistry and …, 2020 - Elsevier
The global dissemination of the novel coronavirus disease (COVID-19) has accelerated the
need for the implementation of effective antimicrobial strategies to target the causative agent …

Phototherapy of Alzheimer's disease: photostimulation of brain lymphatics during sleep: a systematic review

O Semyachkina-Glushkovskaya, T Penzel… - International Journal of …, 2023 - mdpi.com
The global number of people with Alzheimer's disease (AD) doubles every 5 years. It has
been established that unless an effective treatment for AD is found, the incidence of AD will …

Improvements in clinical signs of Parkinson's disease using photobiomodulation: a prospective proof-of-concept study

A Liebert, B Bicknell, EL Laakso, G Heller, P Jalilitabaei… - Bmc Neurology, 2021 - Springer
Background Parkinson's disease (PD) is a progressive neurodegenerative disease with no
cure and few treatment options. Its incidence is increasing due to aging populations, longer …

Very low-level transcranial photobiomodulation for major depressive disorder: the ELATED-3 multicenter, randomized, sham-controlled trial

DV Iosifescu, RJ Norton, U Tural… - The Journal of …, 2022 - psychiatrist.com
Background: Transcranial photobiomodulation (t-PBM) with near-infrared (NIR) light might
represent a treatment for major depressive disorder (MDD). However, the dosimetry of …

Parkinson's disease and photobiomodulation: Potential for treatment

B Bicknell, A Liebert, G Herkes - Journal of Personalized Medicine, 2024 - mdpi.com
Parkinson's disease is the second most common neurodegenerative disease and is
increasing in incidence. The combination of motor and non-motor symptoms makes this a …

Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy …

C McGee, A Liebert, G Herkes, B Bicknell… - Frontiers in …, 2022 - frontiersin.org
Introduction Parkinson's disease (PD) is the second most common, progressive, and
debilitating neurodegenerative disease associated with aging and the most common …

[HTML][HTML] A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study

G Herkes, C McGee, A Liebert, B Bicknell, V Isaac… - …, 2023 - thelancet.com
Background Parkinson's disease is a progressive neurological disease with limited
treatment options. Animal models and a proof-of-concept case series have suggested that …

[HTML][HTML] Transcranial photobiomodulation for the treatment of children with autism spectrum disorder (ASD): a retrospective study

S Pallanti, M Di Ponzio, E Grassi, G Vannini, G Cauli - Children, 2022 - mdpi.com
Children with Autism Spectrum Disorder (ASD) face several challenges due to deficits in
social function and communication along with restricted patterns of behaviors. Often, they …

Microbiome changes in humans with Parkinson's disease after photobiomodulation therapy: A retrospective study

B Bicknell, A Liebert, CS McLachlan, H Kiat - Journal of Personalized …, 2022 - mdpi.com
There is a paucity of information on the effect of photobiomodulation therapy on gut
microbiome composition. Parkinson's disease is a progressive neurological disorder with …

Photobiomodulation as a promising new tool in the management of psychological disorders: A systematic review

A Gutiérrez-Menéndez, M Marcos-Nistal… - Neuroscience & …, 2020 - Elsevier
Photobiomodulation is a brain modulation technique that has become a promising treatment
for multiple pathologies. This systematic review collects studies up to 2019 about the …